XML 18 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2018   93,126,000      
Beginning balance at Dec. 31, 2018 $ 121,763 $ 931 $ 586,940 $ 0 $ (466,108)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]          
Exercise of stock options (in shares) 4,205,000 4,205,000      
Exercise of stock options $ 19,048 $ 42 19,006    
Vesting of restricted stock units (in shares)   479,000      
Vesting of restricted stock units 0 $ 5 (5)    
Issuance of common stock under employee stock purchase plan (in shares)   777,000      
Issuance of common stock under employee stock purchase plan 15,129 $ 8 15,121    
Stock-based compensation 41,928   41,928    
Other comprehensive income (loss) 50     50  
Net loss (99,013)       (99,013)
Ending balance (in shares) at Dec. 31, 2019   98,587,000      
Ending balance at Dec. 31, 2019 $ 98,905 $ 986 662,990 50 (565,121)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]          
Exercise of stock options (in shares) 2,956,000 2,956,000      
Exercise of stock options $ 21,709 $ 29 21,680    
Vesting of restricted stock units (in shares)   1,504,000      
Vesting of restricted stock units 0 $ 15 (15)    
Issuance of common stock under employee stock purchase plan (in shares)   668,000      
Issuance of common stock under employee stock purchase plan 13,040 $ 7 13,033    
Stock-based compensation 59,782   59,782    
Other comprehensive income (loss) (40)     (40)  
Net loss $ (42,731)       (42,731)
Ending balance (in shares) at Dec. 31, 2020 103,715,000 103,715,000      
Ending balance at Dec. 31, 2020 $ 150,665 $ 1,037 757,470 10 (607,852)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]          
Exercise of stock options (in shares) 2,671,000 2,671,000      
Exercise of stock options $ 18,268 $ 26 18,242    
Vesting of restricted stock units (in shares)   1,872,000      
Vesting of restricted stock units 0 $ 19 (19)    
Issuance of common stock under employee stock purchase plan (in shares)   671,000      
Issuance of common stock under employee stock purchase plan 13,736 $ 7 13,729    
Stock-based compensation 79,637   79,637    
Other comprehensive income (loss) (316)     (316)  
Net loss $ (46,677)       (46,677)
Ending balance (in shares) at Dec. 31, 2021 108,929,000 108,929,000      
Ending balance at Dec. 31, 2021 $ 215,313 $ 1,089 $ 869,059 $ (306) $ (654,529)